{"id":"W1761300068","doi":"10.1002/acr.21641","title":"2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","year":2012,"lang":"en","type":"review","venue":"Arthritis Care & Research","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1800,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bombardier (Canada); Toronto General Hospital","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases; University of Alabama at Birmingham; AstraZeneca; Pfizer; University of Alabama; Biogen; Abbott Canada; U.S. Department of Veterans Affairs","keywords":"Rheumatoid arthritis; Medicine; Antirheumatic drugs; Rheumatology; Antirheumatic Agents; Internal medicine; Disease; Alternative medicine; Biologic Agents; Physical therapy; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1834963992528307,"score_gpt":0.4132851218923775,"score_spread":0.2297887226395468,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}